Genmab A/S (NASDAQ:GMAB), a Denmark-based biotechnology company with a market capitalization of $13.4 billion, announced today that it has granted restricted stock units and warrants to its employees.
ADP is in a strong financial position. At the end of fiscal 2024, the balance sheet was fairly conservative with debt/EBITDA of only 0.6 times. We expect ADP's annual operating income will comfortably ...
With Chatmeter’s new Review Generation tool, multi-location brands can build credibility by driving three times more customer reviews in half the time. Customizable email, SMS and QR code templates ...